Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma

ClinicalTrials.gov ID: NCT00393952

Public ClinicalTrials.gov record NCT00393952. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 8:50 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel Group, Stratified, Multi-center, 12-Week Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm(tm) 100/10 µg or 250/10 µg Twice Daily) in a Single Inhaler (SkyePharma HFA pMDI) With the Administration of Placebo or Fluticasone (250 µg Twice Daily) and Formoterol (10 µg Twice Daily) Alone in Adolescent and Adult Patients With Moderate to Severe Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the efficacy and safety of the fixed combination asthma drug FlutiForm with its two components administered alone, fluticasone propionate and formoterol fumarate, and with placebo in adult and adolescent patients with moderate to severe asthma.

Study identification

NCT ID
NCT00393952
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
SkyePharma AG
Industry
Enrollment
557 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2006 (Type not available)
Primary completion
Apr 2008 (Actual)
Completion
Apr 2008 (Actual)
Last update posted
Jun 23, 2011

2006 – 2008

United States locations

U.S. sites
62
U.S. states
26
U.S. cities
56
Facility City State ZIP Site status
Research Center Pell City Alabama 35128 —
Research Site Glendale Arizona 85306 —
Research Center Phoenix Arizona 85050 —
Research Site Phoenix Arizona 85050 —
Research Site Tucson Arizona 85712 —
Research Site Jonesboro Arkansas 72401 —
Research Site Little Rock Arkansas 72205 —
Research Site Burbank California 91505 —
Research Site Fresno California 93720 —
Research Site Long Beach California 90806 —
Research Site Los Angeles California 90025 —
Research Center Los Angeles California 90048 —
Research Site Los Angeles California 90048 —
Research Site Mission Viejo California 92691 —
Research Site Monterey Park California 91754 —
Research Site Palmdale California 93551 —
Research Site Sacramento California 95819 —
Research Site San Diego California 92120 —
Research Site San Diego California 92123 —
Research Site San Jose California 95128 —
Research Center Gainesville Florida 32605 —
Research Site Hialeah Florida 33013 —
Research Site Ormond Beach Florida 32174 —
Research Center Panama City Florida 32405 —
Research Site Pensacola Florida 32503 —
Research Site Tampa Florida 33613 —
Research Center Congers Georgia 30012 —
Research Site Savannah Georgia 31406 —
Research Site Round Lake Beach Illinois 60073 —
Research Site Louisville Kentucky 40215 —
Research Site Baltimore Maryland 21236 —
Research Site North Dartmouth Massachusetts 02747 —
Research Site Taunton Massachusetts 02780 —
Research Center Minneapolis Minnesota 55402 —
Research Site Minneapolis Minnesota 55402 —
Research Site Plymouth Minnesota 55441 —
Research Site St Louis Missouri 63141 —
Research Site Bozeman Montana 59718 —
Research Site Omaha Nebraska 68130 —
Research Site Las Vegas Nevada 89123 —
Research Site Brick New Jersey 08724 —
Research Site Mount Laurel New Jersey 08054 —
Research Site Skillman New Jersey 08558 —
Research Site Tinton Falls New Jersey 07001 —
Research Site Rockville Centre New York 11570 —
Research Site Oklahoma City Oklahoma 73139 —
Research Site Ashland Oregon 97520 —
Research Site Medford Oregon 97504 —
Research Center Portland Oregon 97213 —
Research Center Upland Pennsylvania 19013 —
Research Site Lincoln Rhode Island 02865 —
Research Center Anderson South Carolina 29621 —
Research Site Greenville South Carolina 29607 —
Research Site Austin Texas 78750 —
Research Site Dallas Texas 75231 —
Research Site El Paso Texas 79902 —
Research Center Fort Worth Texas 76104 —
Research Site San Antonio Texas 72205 —
Research Site San Antonio Texas 78229 —
Research Site Richmond Virginia 23225 —
Research Site Tacoma Washington 98405 —
Research Site Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00393952, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2011 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00393952 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →